MY129773A - An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine - Google Patents
An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccineInfo
- Publication number
- MY129773A MY129773A MYPI98003899A MYPI9803899A MY129773A MY 129773 A MY129773 A MY 129773A MY PI98003899 A MYPI98003899 A MY PI98003899A MY PI9803899 A MYPI9803899 A MY PI9803899A MY 129773 A MY129773 A MY 129773A
- Authority
- MY
- Malaysia
- Prior art keywords
- japanese encephalitis
- vero cell
- attenuated
- vaccine
- virus adapted
- Prior art date
Links
- 230000002238 attenuated effect Effects 0.000 title abstract 3
- 210000003501 vero cell Anatomy 0.000 title abstract 3
- 229940124726 Japanese encephalitis vaccine Drugs 0.000 title abstract 2
- 241000710842 Japanese encephalitis virus Species 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19970042001 | 1997-08-28 | ||
KR19970042002 | 1997-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY129773A true MY129773A (en) | 2007-04-30 |
Family
ID=26633032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI98003899A MY129773A (en) | 1997-08-28 | 1998-08-26 | An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
Country Status (15)
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
KR20010032699A (ko) | 1998-10-05 | 2001-04-25 | 무따이 마사히꼬 | 일본 뇌염 바이러스 감염에 대한 불활성 백신을 위한증강된 면역원 및 그 제조방법 |
ES2348159T3 (es) * | 1999-04-22 | 2010-11-30 | United States Department Of Agriculture | Vacuna contra el sindrome respiratorio y reproductivo porcino basada en el aislado ja-142. |
AU4472801A (en) * | 2000-04-07 | 2001-10-23 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Inactivated japanese B encephalitis vaccine and process for producing the same |
EP1416986A4 (en) * | 2001-06-29 | 2005-12-14 | Becton Dickinson Co | INTRADERMIC DISTRIBUTION OF VACCINES AND GENE THERAPEUTIC AGENTS VIA MICROCANNULE |
JP2007068401A (ja) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | 西ナイルウイルスワクチン |
ES2329607T3 (es) * | 2004-02-23 | 2009-11-27 | Crucell Holland B.V. | Metodos de purificacion de virus. |
CN100340596C (zh) * | 2004-05-20 | 2007-10-03 | 佛山市顺德区汉达精密电子科技有限公司 | 回收聚碳酸酯/丙烯腈-丁二烯-苯乙烯共聚物及其回收方法 |
ATE412737T1 (de) * | 2005-04-11 | 2008-11-15 | Crucell Holland Bv | Virusreinigung mit ultrafiltration |
CA2676775A1 (en) * | 2007-01-31 | 2008-09-25 | Sanofi Pasteur Biologics Co. | Flavivirus vaccine vector against influenza virus |
US9453055B2 (en) | 2007-12-26 | 2016-09-27 | Kitasato Daiichi Sankyo Vaccine Co., Ltd. | Method of producing japanese encephalitis vaccine stably storable over long time and use of the vaccine |
EP2298344B1 (en) * | 2008-06-04 | 2016-08-17 | The Chemo-Sero-Therapeutic Research Institute | Use of inactivated japanese encephalitis virus particle as adjuvant |
WO2010013601A1 (ja) * | 2008-07-30 | 2010-02-04 | 久光製薬株式会社 | マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法 |
WO2010137036A2 (en) * | 2009-05-25 | 2010-12-02 | Panacea Biotec Ltd | Novel japanese encephalitis vaccine and method of manufacturing the same |
KR101144993B1 (ko) * | 2009-06-18 | 2012-06-27 | 대한민국 | 돼지 일본뇌염 바이러스의 고농축 혈구응집용 항원 |
DK2788023T3 (en) | 2011-12-06 | 2016-12-19 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
IN2013CH04135A (US06559137-20030506-C00021.png) * | 2013-09-14 | 2015-08-14 | Bharat Biotech Int Ltd | |
CN105695424B (zh) * | 2015-04-01 | 2019-06-14 | 中国食品药品检定研究院 | 乙型脑炎减毒活疫苗株sa14-14-2在人二倍体细胞2bs上的适应株及其疫苗 |
CA3009278A1 (en) * | 2015-12-23 | 2017-06-29 | Valneva Austria Gmbh | Zika virus vaccine |
JP6941566B2 (ja) * | 2016-01-15 | 2021-09-29 | Kmバイオロジクス株式会社 | 固定化ウイルス粒子を含むワクチン |
US11033615B2 (en) | 2016-05-31 | 2021-06-15 | The Government of the United States, As Represented by the Secretary of the Army Fort Detrick, Maryland | Zika virus vaccine and methods of production |
KR20200056982A (ko) | 2017-09-21 | 2020-05-25 | 발네바 에스이 | 면역원성 치쿤구니야 바이러스 chikv-델타5nsp3을 포함하는 약제학적 조성물의 생산 방법 |
US11648304B2 (en) | 2017-11-03 | 2023-05-16 | Takeda Vaccines, Inc. | Zika vaccines and immunogenic compositions, and methods of using the same |
CA3084605A1 (en) | 2017-11-30 | 2019-06-06 | Takeda Vaccines, Inc. | Method for inactivating zika virus and related methods |
CN110684747B (zh) * | 2018-07-06 | 2024-05-24 | 厦门大学 | 灭活及保存呼吸道合胞病毒的方法 |
WO2020045368A1 (ja) * | 2018-08-27 | 2020-03-05 | マイキャン・テクノロジーズ株式会社 | 不死化単球細胞および誘導細胞を用いた抗感染症薬,ワクチンなどの評価方法 |
IL296071A (en) | 2020-03-01 | 2022-11-01 | Valneva Austria Gmbh | Sars-cov-2 virus vaccine with adjuvant cytidine-phosphoguanosine |
EP3895729A1 (en) | 2020-03-01 | 2021-10-20 | Valneva Austria GmbH | Cpg-adjuvanted sars-cov-2 virus vaccine |
WO2021204825A2 (en) | 2020-04-06 | 2021-10-14 | Valneva Austria Gmbh | INACTIVATED SARS-CoV-2 VIRUS VACCINE |
WO2023148256A1 (en) | 2022-02-02 | 2023-08-10 | Valneva Austria Gmbh | Inactivated sars-cov-2 virus vaccine |
WO2024153686A1 (en) | 2023-01-18 | 2024-07-25 | Valneva Austria Gmbh | Process for virus production in a bioreactor |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2704258B2 (ja) * | 1987-10-31 | 1998-01-26 | 日本臓器製薬株式会社 | 組み換えワクチニアウイルス |
GB8821656D0 (en) * | 1988-09-15 | 1988-10-12 | Health Lab Service Board | Pharmaceutical compositions for eliciting immunostimulant effect |
JPH085803B2 (ja) * | 1988-11-10 | 1996-01-24 | 武田薬品工業株式会社 | 日本脳炎ワクチンの製造法 |
EP0562136A1 (en) * | 1992-03-24 | 1993-09-29 | Division Of Microbiology, Kyoto Biken Laboratories, Inc. | Live vaccine to getah virus infectious disease, and trivalent live vaccine to Japanese encephalitis virus, porcine parvovirus and getah virus infectious diseases |
US6010894A (en) * | 1997-06-13 | 2000-01-04 | Research Development Foundation | Method of screening for attenuating viruses |
-
1998
- 1998-08-25 AU AU90047/98A patent/AU748730B2/en not_active Expired
- 1998-08-25 JP JP2000508774A patent/JP4161017B2/ja not_active Expired - Lifetime
- 1998-08-25 ES ES98941885T patent/ES2281929T3/es not_active Expired - Lifetime
- 1998-08-25 DK DK98941885T patent/DK1025209T3/da active
- 1998-08-25 DE DE122009000037C patent/DE122009000037I2/de active Active
- 1998-08-25 NZ NZ503522A patent/NZ503522A/en not_active IP Right Cessation
- 1998-08-25 WO PCT/KR1998/000259 patent/WO1999011762A1/en active IP Right Grant
- 1998-08-25 US US09/486,392 patent/US6309650B1/en not_active Expired - Lifetime
- 1998-08-25 ES ES05014317T patent/ES2382946T3/es not_active Expired - Lifetime
- 1998-08-25 EP EP05014317A patent/EP1604685B1/en not_active Expired - Lifetime
- 1998-08-25 DK DK05014317.1T patent/DK1604685T3/da active
- 1998-08-25 EP EP98941885A patent/EP1025209B1/en not_active Expired - Lifetime
- 1998-08-25 CA CA002301000A patent/CA2301000C/en not_active Expired - Lifetime
- 1998-08-25 CN CNB988097974A patent/CN1142271C/zh not_active Expired - Lifetime
- 1998-08-25 DE DE69837211T patent/DE69837211T2/de not_active Expired - Lifetime
- 1998-08-26 MY MYPI98003899A patent/MY129773A/en unknown
- 1998-08-27 KR KR1019980035007A patent/KR100314404B1/ko not_active IP Right Cessation
-
2009
- 2009-06-10 NL NL300391C patent/NL300391I2/nl unknown
- 2009-08-14 FR FR09C0037C patent/FR09C0037I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
NL300391I2 (nl) | 2009-11-02 |
WO1999011762A1 (en) | 1999-03-11 |
KR19990023955A (ko) | 1999-03-25 |
EP1604685A3 (en) | 2006-07-05 |
NZ503522A (en) | 2001-06-29 |
CA2301000A1 (en) | 1999-03-11 |
DE69837211D1 (de) | 2007-04-12 |
AU748730B2 (en) | 2002-06-13 |
DK1025209T3 (da) | 2007-06-25 |
KR100314404B1 (ko) | 2002-10-12 |
EP1025209B1 (en) | 2007-02-28 |
NL300391I1 (nl) | 2009-08-03 |
FR09C0037I2 (fr) | 2021-11-05 |
EP1604685A2 (en) | 2005-12-14 |
DE122009000037I2 (de) | 2011-06-16 |
US6309650B1 (en) | 2001-10-30 |
CN1142271C (zh) | 2004-03-17 |
CN1272879A (zh) | 2000-11-08 |
AU9004798A (en) | 1999-03-22 |
EP1604685B1 (en) | 2012-02-22 |
CA2301000C (en) | 2003-07-08 |
EP1025209A1 (en) | 2000-08-09 |
DE122009000037I1 (de) | 2009-11-05 |
FR09C0037I1 (US06559137-20030506-C00021.png) | 2009-09-25 |
DE69837211T2 (de) | 2007-12-06 |
ES2281929T3 (es) | 2007-10-01 |
JP4161017B2 (ja) | 2008-10-08 |
DK1604685T3 (da) | 2012-06-18 |
ES2382946T3 (es) | 2012-06-14 |
JP2001514844A (ja) | 2001-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY129773A (en) | An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine | |
TW354765B (en) | Catheter hub to nose engagement | |
KR970702965A (ko) | 연료압력 진공반응식 비귀환 연료시스템(non-return fuel system with fuel pressure vaccum response) | |
DE69632978D1 (de) | Multi-Operand-Addierer, der Parallelzähler benutzt | |
HK1021181A1 (en) | (tetrahydro-3-furanyl) methylamine | |
MX9700486A (es) | Ligando para receptor de cinasa transmembranal de hepatoma. | |
EP0676954A4 (en) | HIV LOCK VIRUS. | |
EP0811013A4 (en) | ISOLATED NONAPEPTIDES PRESENTED BY HLA MOLECULES, AND USE THEREOF | |
AU7501898A (en) | Live attenuated virus vaccines for equine encephalitis viruses | |
DE69020121D1 (de) | Gasbetriebenes Kochfeld. | |
EP0643263A3 (en) | Illuminating combustion system. | |
EP0681928A3 (en) | Improved pneumatic tire for aircraft. | |
ZA997011B (en) | Attenuated forms of bovine viral diarrhea virus. | |
FI920983A0 (fi) | Takmekanism foer en oeppen bils skyddstak som gaor att oeppna. | |
DK0811599T3 (da) | Antivirale forbindelser | |
HK1001404A1 (en) | Isolated, tyrosinase derived peptides and uses thereof. | |
ZA9711555B (en) | Face masks. | |
AU1875199A (en) | Safety system and device, as well as safety enhancing process appropriate therefor | |
ES2159815T3 (es) | Compuestos antivirales. | |
GR3035980T3 (en) | Anti-viral compounds | |
FR2704931B1 (fr) | Réservoir notamment bouteille de gaz. | |
FI974367A (fi) | Kasvojen yhteydessä käytettävä suoja, erityisesti sukeltajan maski | |
EP0685684A3 (de) | Atmosphärischer Gasbrenner. | |
TW348157B (en) | Equipment and method to hold and to protect objects | |
GB9302176D0 (en) | Cylinder leak indicator cap (c.l.i.c.) |